Externa
1 known investors
Externa develops biologics using genetic code expansion, a technology aimed at incorporating synthetic amino acids into proteins of any type and size. The company positions its platform for partnerships in protein and biologics development.
Investors · 1
Frequently asked questions
- What does Externa do?
- Externa develops biologics using genetic code expansion, a technology aimed at incorporating synthetic amino acids into proteins of any type and size. The company positions its platform for partnerships in protein and biologics development.
- Who are Externa's investors?
- Externa's investors include Fifty Years.